Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness cost

Camille Bédard(Université Laval), Christian R. Landry(PROTEO), Jonathan Boisvert(PROTEO), Anna Fijarczyk(PROTEO), Jehoshua Sharma(University of Guelph), Alexandre K. Dubé(PROTEO), Isabelle Gagnon‐Arsenault(PROTEO), Laetitia Maroc(University of Guelph), Samuel Plante(PROTEO), Rebecca S. Shapiro(University of Guelph), Alicia Pageau(PROTEO)
bioRxiv (Cold Spring Harbor Laboratory)
December 14, 2023
Cited by 6


Related Papers